Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04206748 · ClinicalTrials.gov registry record · NA
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
A NA study of Gestational Diabetes and Type2 Diabetes, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04206748 is a NA study of Gestational Diabetes and Type2 Diabetes that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 200 participants, below the 317-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04206748, a NA study of Gestational Diabetes and Type2 Diabetes, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
Conditions Studied
Interventions
- DEVICE iGlucose Smart Meter System
- DEVICE Routine Care-RX meter
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2022-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04206748
The ClinicalTrials.gov registry entry for NCT04206748 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 317-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (37% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which iGlucose Smart Meter System is the first listed.
NCT04206748 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04206748 about?
NCT04206748 is a clinical study titled "iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes". The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
What is the current status of trial NCT04206748?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2019-11-12. Estimated completion is 2022-11-01.
What conditions does trial NCT04206748 study?
This clinical trial studies the following conditions: Gestational Diabetes, Type2 Diabetes, Pregnancy in Diabetic.
What interventions are being tested in trial NCT04206748?
The interventions under investigation include: iGlucose Smart Meter System (DEVICE), Routine Care-RX meter (DEVICE).
Who is sponsoring clinical trial NCT04206748?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04206748 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
-
Preventing T2DM After GDM With Immediate Postpartum Screening
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.